Clinical Trial

Immunomonitoring of Breast Cancer Patients During Systemic Treatment

Study acronym: IMMUNE CAPTURE
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to constitute a most complete biological collection for patients treated for localized or metastatic breast cancer (in different cohorts depending on the type of systemic treatment received), in order to describe the basal immune response of patients treated for a breast cancer according to the stage of the disease, but above all to study how the different systemic treatments used in the management of breast cancer modulate this immune response.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-06-08; most recent amendment 2023-10-16.
Trial Details
NCT Number NCT04925856
Lead Sponsor Centre Georges Francois Leclerc
Conditions Breast Cancer
Enrollment 150 participants
Start Date 2020-05-26
Primary Completion 2030-05-26 (estimated)
Study Completion 2030-05-26 (estimated)
Updated on ClinicalTrials.gov 2023-10-17